Inactive Instrument

All News VentriPoint Diagnostics Ltd. Toronto S.E.

Equities

VPT

CA92281P2008

All News

Unlock all the news: Be the first to know and act before the market!

Ventripoint to Present its AI-enhanced Cardiac Ultrasound Technology to B.C. and Canadian Health Care Leaders at The Data Effect	Jun. 24	AQ
Ventripoint Diagnostics Ltd. Appoints Matt Dobson as Marketing Director	Jun. 13	CI
Ventripoint Welcomes Matt Dobson as Marketing Director to Guide Market Development and Product Management	Jun. 13	AQ
Ventripoint Diagnostics Announces Shareholder Update and Teleconference	Jun. 11	AQ
Ventripoint Diagnostics Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 30	CI
Ventripoint Diagnostics Ltd. Submits Next Generation of Software, VMS+4.0, to the U.S. Food and Drug Administration	May. 06	CI
Ventripoint's Next Generation, AI-powered Heart-scanning Technology Submitted to U.S Food and Drug Administration	May. 06	AQ
Duke University Health Center Purchases Ventripoint's AI Heart-Scan Technology	May. 01	CI
Duke University Health Center -- One of America's Top Heart-care Institutions and Innovators -- Purchases Ventripoint's AI Heart-scan Technology	May. 01	AQ
Ventripoint Diagnostics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
VentriPoint Diagnostics Ltd. announced that it expects to receive CAD 3 million in funding	Apr. 10	CI
Ventripoint Diagnostics Provides Corporate Update and Announces Conference Call	Mar. 28	AQ
Ventripoint Diagnostics Ltd. Releases Significant Upgrade to the Design and Function of Its Whole-Heart Analysis System (VMS+3.2)	Mar. 04	CI
Enhanced Design Breakthrough Makes Ventripoint's VMS+ Even Simpler to Use	Mar. 04	AQ
Ventripoint Diagnostics Ltd. Showcases A.I. Powered Heart-Scanning Technology at International Cardiology Conferences	Feb. 20	CI
Ventripoint Successfully Showcases A.I.-Powered Heart-Scanning Technology at Prestigious International Cardiology Conferences	Feb. 20	AQ
Ventripoint Announces Changes to The Board of Directors	Feb. 13	AQ
Ventripoint Diagnostics Ltd. Appoints Hugh Macnaught as Interim CEO	Feb. 05	CI
Ventripoint Diagnostics Ltd. Appoints Hugh Macnaught as President	Feb. 05	CI
Ventripoint Begins 2024 with Leadership Change	Feb. 05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News VentriPoint Diagnostics Ltd. Toronto S.E.

Equities

VPT

CA92281P2008

All News

Filters